DI IANNI, MAURO
 Distribuzione geografica
Continente #
NA - Nord America 2.896
EU - Europa 1.837
AS - Asia 1.637
SA - Sud America 75
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 4
Totale 6.465
Nazione #
US - Stati Uniti d'America 2.880
SG - Singapore 797
CN - Cina 511
IT - Italia 433
IE - Irlanda 359
SE - Svezia 348
TR - Turchia 272
UA - Ucraina 238
DE - Germania 135
GB - Regno Unito 76
RU - Federazione Russa 71
BR - Brasile 69
FR - Francia 49
FI - Finlandia 27
NL - Olanda 18
HK - Hong Kong 17
BE - Belgio 16
GR - Grecia 12
VN - Vietnam 12
AT - Austria 11
CA - Canada 9
RO - Romania 9
ES - Italia 8
MX - Messico 7
CZ - Repubblica Ceca 6
EU - Europa 6
PK - Pakistan 6
HU - Ungheria 4
IN - India 4
MA - Marocco 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
AU - Australia 3
JP - Giappone 3
MY - Malesia 3
PL - Polonia 3
VE - Venezuela 3
AZ - Azerbaigian 2
CH - Svizzera 2
DK - Danimarca 2
EE - Estonia 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BD - Bangladesh 1
BG - Bulgaria 1
BJ - Benin 1
CL - Cile 1
EC - Ecuador 1
EG - Egitto 1
HR - Croazia 1
IQ - Iraq 1
JO - Giordania 1
KE - Kenya 1
LK - Sri Lanka 1
MD - Moldavia 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
UZ - Uzbekistan 1
Totale 6.465
Città #
Singapore 591
Chandler 550
Jacksonville 403
Dublin 356
Princeton 176
Ashburn 153
Izmir 153
Nanjing 138
Santa Clara 133
Altamura 93
Dearborn 89
The Dalles 78
Cambridge 72
Beijing 71
Ann Arbor 68
Boardman 68
Pescara 68
Wilmington 64
Los Angeles 60
Nanchang 56
Chieti 36
Woodbridge 35
Washington 33
Hebei 29
Kunming 22
Tianjin 21
Milan 20
Shenyang 20
Norwalk 19
Hong Kong 17
Seattle 17
Romola 16
Jiaxing 14
Helsinki 13
Rome 13
Brussels 12
Dong Ket 12
Nuremberg 12
Hangzhou 11
Chicago 10
Lappeenranta 10
Munich 9
Kocaeli 8
London 8
Shanghai 8
Changsha 7
Changchun 6
Düsseldorf 6
Frankfurt am Main 6
Jinan 6
L'aquila 6
Lanzhou 6
San Martino In Pensilis 6
São Paulo 6
Vienna 6
Bologna 5
Brno 5
Francavilla al Mare 5
Paris 5
Terni 5
Amsterdam 4
Ascoli Piceno 4
Guangzhou 4
Hefei 4
Islamabad 4
Istanbul 4
L’Aquila 4
Madrid 4
Moscow 4
New York 4
San Benedetto del Tronto 4
Shenzhen 4
Zhengzhou 4
Carugate 3
Martinsicuro 3
Mumbai 3
Nanning 3
Newark 3
Ningbo 3
Phoenix 3
San Francisco 3
Toronto 3
Turku 3
Warsaw 3
Xi'an 3
Ancona 2
Andover 2
Araras 2
Baku 2
Belo Horizonte 2
Bergamo 2
Brasília 2
Cepagatti 2
Clifton 2
Dalian 2
Fuzhou 2
Gallarate 2
Ghent 2
Harbin 2
Houston 2
Totale 4.069
Nome #
A novel, non-canonical splice variant of the Ikaros gene is aberrantly expressed in B-cell lymphoproliferative disorders. 107
beta-galactosidase transduced T lymphocytes: a comparison between stimulation by either PHA and IL-2 or a mixed lymphocyte reaction. 104
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation 104
T lymphocyte transduction with herpes simplex virus-thymidine kinase (HSV-tk) gene: comparison of four different infection protocols. 102
Constitutive phosphorylation of the active Notch1 intracellular domain in chronic lymphocytic leukemia cells with NOTCH1 mutation 99
NOTCH and NF-κB interplay in chronic lymphocytic leukemia is independent of genetic lesion 99
B-chronic lymphocytic leukemia cells exert an in vitro cytotoxicity mediated by tumor necrosis factor α 97
Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo 96
Treg-protected donor lymphocyte infusions: a new tool to address the graft-versus-leukemia effect in the absence of graft-versus-host disease in patients relapsed after HSCT 95
A revised NOTCH1 mutation frequency still impacts survival while the allele burden predicts early progression in chronic lymphocytic leukemia 93
Primary eyelid plasmacytoma 93
5-Azacytidine prevents transgene methylation in vivo 90
Clinical-Grade-Expanded Regulatory T Cells Prevent Graft-versus-Host Disease While Allowing a Powerful T Cell-Dependent Graft-versus-Leukemia Effect in Murine Models 89
Secondary solid cancer following hematopoietic cell transplantation in patients with thalassemia major 88
Treating two concurrent B-cell and T-cell lymphoid neoplasms with alemtuzumab monotherapy 88
To breathe or not to breathe: The haematopoietic stem/progenitor cells dilemma 88
Retroviral transfer of herpes simplex virus-thymidine kinase and beta-galactosidase genes into U937 cells with bicistronic vector 88
G-CSF-induced thrombocytopenia in a healthy donor 86
NeoR-based transduced T lymphocytes detected by real-time quantitative polymerase chain reaction 86
MtDNA mutation associated with mitochondrial dysfunction in megakaryoblastic leukaemic cells 86
Next generation HLA-haploidentical HSCT 85
CAR-T-Derived Extracellular Vesicles: A Promising Development of CAR-T Anti-Tumor Therapy 83
Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: Implications for cellular-based therapy 83
Tregs: Hype or hope for allogeneic hematopoietic stem cell transplantation? 82
Comparison between adenoviral and retroviral vectors for the transduction of the thymidine kinase PET reporter gene in rat mesenchymal stem cells 82
A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia 82
Effect of trichostatin a and 5'-azacytidine on transgene reactivation in U937 transduced cells 81
Retrovirus-mediated transfer of the herpes simplex virus thymidine kinase and enhanced green fluorescence protein genes in primary T lymphocytes 81
Striking response to intrathecal liposomal cytarabine in a patient with meningeal myelomatosis [1] 81
Minimum information about T regulatory cells: A step toward reproducibility and standardization 81
Prognostic significance of genetic variants in the IL-23/Th17 pathway for the outcome of T cell-depleted allogeneic stem cell transplantation 80
Evidence of jak2 val617phe positive essential thrombocythemia with splanchnic thrombosis during estroprogestinic treatment 80
Novel targets for endoplasmic reticulum stress-induced apoptosis in B-CLL 79
Hematopoietic stem/progenitor cells express myoglobin and neuroglobin: Adaptation to hypoxia or prevention from oxidative stress? 79
Mesenchymal cells: A vehicle for gene therapy 78
The rs5743836 polymorphism in TLR9 confers a population-based increased risk of non-Hodgkin lymphoma 77
Ibrutinib treatment of a patient with relapsing chronic lymphocytic leukemia and sustained remission of Richter syndrome 76
Clinical-Grade Expanded Regulatory T Cells Are Enriched with Highly Suppressive Cells Producing IL-10, Granzyme B, and IL-35 76
Mesenchymal cells recruit and regulate T regulatory cells 75
Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells 75
Chronic myeloproliferative disorders: The bone marrow stromal component is not involved in the malignant clone [13] 75
Interleukin-7-Engineered Mesenchymal Cells: In Vitro Effects on Naive T-Cell Population 75
T-lymphocyte function after retroviral-mediated thymidine kinase gene transfer and G418 selection 74
CD34+ cells from AML with mutated NPM1 harbor cytoplasmic mutated nucleophosmin and generate leukemia in immunocompromised mice 73
NOTCH1 PEST domain mutation is an adverse prognostic factor in B-CLL 73
Transformation by retroviral vectors of bone marrow-derived mesenchymal cells induces mitochondria-dependent cAMP-sensitive reactive oxygen species production 73
Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: The extended DACUS study 72
Recurrent primary plasmacytoma of the eyelid with rapid regional metastasis 72
"Designed" grafts for HLA-haploidentical stem cell transplantation 72
T regulatory cell separation for clinical application 71
γ-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and notch down-regulation. 71
Interleukin 7-engineered stromal cells: A new approach for hastening naive T cell recruitment 71
Unusual onset of venous thromboembolism and heparin-induced thrombocytopenia in a patient with essential thrombocythemia 71
NOTCH and graft-versus-host disease 71
Toxic epidermal necrolysis in a patient with primary myelofibrosis receiving thalidomide therapy 70
The iron chelator deferasirox affects redox signalling in haematopoietic stem/progenitor cells 70
Immunoselection and clinical use of T regulatory cells in HLA-haploidentical stem cell transplantation 70
NOTCH1 aberrations in Chronic lymphocytic leukemia 70
Notch signaling sustains the expression of Mcl-1 and the activity of eIF4E to promote cell survival in CLL 70
The NOTCH1/CD39 axis: A Treg trip-switch for GvHD 69
Homing and survival of thymidine kinase-transduced human T cells in NOD/SCID mice 69
NK Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications 69
High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk Hodgkin's lymphoma 66
Hematopoietic stem cell transplantation from alternative donors for high-risk acute leukemia: the haploidentical option 65
Melphalan versus melphalan plus busulphan in conditioning to autologous stem cell transplantation for low-risk multiple myeloma 64
In vivo demethylation of a MoMuLV retroviral vector expressing the herpes simplex thymidine kinase suicide gene by 5' azacytidine. 64
IL-4-dependent Jagged1 expression/processing is associated with survival of chronic lymphocytic leukemia cells but not with Notch activation 64
High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk non-Hodgkin lymphoma 63
A novel NOTCH1 PEST domain mutation in a case of chronic lymphocytic leukemia 63
Immunomagnetic isolation of CD4+CD25+FoxP3 + natural T regulatory lymphocytes for clinical applications 63
NOTCH1 is aberrantly activated in chronic lymphocytic leukemia hematopoietic stem cells 63
Loss of bone mineral density and secondary hyperparathyroidism are complications of autologous stem cell transplantation 62
A new genetic lesion in B-CLL: A NOTCH1 PEST domain mutation 62
Graft engineering for allogeneic haploidentical stem cell transplantation 62
Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity 61
NOTCH1 Activation Negatively Impacts on Chronic Lymphocytic Leukemia Outcome and Is Not Correlated to the NOTCH1 and IGHV Mutational Status 60
Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia 59
Association of Platelet Thromboxane Inhibition by Low-Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia 57
NOTCH1 inhibition prevents GvHD and maintains GvL effect in murine models 56
Large-scale generation of human allodepleted anti-3rd party lymphocytes 54
Notch1 modulates mesenchymal stem cells mediated regulatory T-cell induction 54
A microelectronic DNA chip detects the V617F JAK-2 mutation in myeloproliferative disorders [6] 53
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 52
Polymorphisms in Toll-like receptor genes and susceptibility to infections in allogeneic stem cell transplantation 51
Donor lymphocyte infusions after haploidentical stem cell transplantation with PTCY: A study on behalf of the EBMT cellular therapy & immunobiology working party 50
NPM1-mutated acute myeloid leukaemia occurring in JAK2-V617F+ primary myelofibrosis: De-novo origin? 49
Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia 48
Cellular Strategies for Separating GvHD from GvL in Haploidentical Transplantation 45
Exploring the Immunomodulatory Potential of Pancreatic Cancer-Derived Extracellular Vesicles through Proteomic and Functional Analyses 43
Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia 43
Comparison between peripheral blood progenitor cell collection on the 4th or 5th day of granulocyte colony-stimulating factor treatment in allogeneic stem cell donors: implications for hematopoietic progenitor cell apheresis guidelines 41
Prednisone vs high-dose dexamethasone in newly diagnosed adult primary immune thrombocytopenia: a randomized trial 38
Precision Medicine Approaches in Acute Myeloid Leukemia with Adverse Genetics 36
Allogeneic stem cell transplantation in multiple myeloma: is there still a place? 34
Long‐term pharmacodynamic and clinical effects of twice‐ versus once‐daily low‐dose aspirin in essential thrombocythemia: The ARES trial 34
Case Report: Invasive fungal infection after anti-CD19 CAR-T cell therapy. Implication for antifungal prophylaxis 32
The absent/low expression of CD34 in NPM1-mutated AML is not related to cytoplasmic dislocation of NPM1 mutant protein 30
Novel Approaches to Treatment of Acute Myeloid Leukemia Relapse Post Allogeneic Stem Cell Transplantation 29
GSK3β is a critical, druggable component of the network regulating the active NOTCH1 protein and cell viability in CLL 27
Myelofibrosis and allogeneic transplantation: critical points and challenges 26
Totale 6.968
Categoria #
all - tutte 31.746
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.746


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020107 0 0 0 0 0 0 0 0 0 0 92 15
2020/2021482 40 6 89 11 15 157 8 8 26 26 2 94
2021/2022409 2 9 18 40 37 9 7 33 33 40 39 142
2022/20231.476 120 195 85 188 171 269 74 117 156 17 43 41
2023/2024698 54 23 60 29 67 155 153 36 22 45 10 44
2024/20252.010 121 542 502 86 46 80 104 126 187 84 132 0
Totale 7.140